Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.38 0.05

Resumen

Variación precio

24h

Actual

Mínimo

18.37

Máximo

18.39

Métricas clave

By Trading Economics

Ingresos

-960K

3.6M

Ventas

-2.4M

22M

P/B

Media del Sector

45.9

57.371

BPA

0.3

Margen de beneficios

16.335

Empleados

212

EBITDA

-6.3M

1.1M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-6.15% downside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

154K

371M

Apertura anterior

18.33

Cierre anterior

18.38

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 ago 2026, 22:01 UTC

News

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

21 ago 2026, 20:07 UTC

News
Social Media

Microsoft shares are higher, supported by bullish options activity and a reaffirmed AAA rating from Moody's. The company is part of a $615 billion AI investment group.

21 ago 2026, 20:07 UTC

Social Media
News

Palantir Technologies shares are higher today amid increased options trading and positive sentiment, with Deutsche Bank reiterating a $200 price target.

21 ago 2026, 20:07 UTC

News

Aflac shares are lower today as Japan Post sold 12,700 shares, contributing to negative sentiment amid broader market declines since Thursday's close.

21 ago 2026, 20:07 UTC

News

United Parcel Service shares are trading lower as Zacks cuts Q3 EPS estimate to $1.60. Susquehanna raises target price to $120, maintaining a neutral rating.

21 ago 2026, 20:07 UTC

News

Barclays maintains an Overweight rating on Hims & Hers Health, lowering its price target to $35. Shares are trading higher amid positive market sentiment.

21 ago 2026, 20:07 UTC

News
Correlated Moves

The USD/SEK is trading lower today, continuing a decline since Thursday's close. Earlier in the session, the dollar rebounded from a session low.

21 ago 2026, 20:06 UTC

News

Nu Holdings is higher today, buoyed by a rise in Bitcoin prices following the U.S. Treasury's announcement to double long-dated bond buybacks.

21 ago 2026, 20:06 UTC

News
Correlated Moves

Gold prices are rising, reaching a near three-month high, driven by U.S. Treasury bond buybacks and President Trump's shift in Iran policy.

21 ago 2026, 20:06 UTC

Correlated Moves
News

First Western Financial promotes Brian Weldon to Regional President and Bryce Parietti and Rob Miles to Market Presidents, with shares trading higher today.

21 ago 2026, 20:06 UTC

News
Social Media

JPMorgan raises Okta price target to $165; shares modestly higher.

21 ago 2026, 20:06 UTC

News

Liquidity Services shares are higher after announcing CEO Bill Angrick's presentation at the Midwest IDEAS Investor Conference on August 26, 2026, in Chicago.

21 ago 2026, 20:06 UTC

News

Palo Alto Networks shares are higher following multiple analyst price target increases, including Cantor Fitzgerald's raise to $425 from $340.

21 ago 2026, 20:06 UTC

News

Citizens Inc shares are lower today, continuing a decline since Thursday amid broader market downturns. The stock remains below its 20-day moving average.

21 ago 2026, 20:06 UTC

News
Social Media

Stoke Therapeutics shares rise following analyst reinstatement with Overweight rating and $40 price target, amid positive sentiment for zorevunersen’s phase III EMPEROR trial.

21 ago 2026, 20:06 UTC

News

T Rowe Price shares are lower as the company pursues its acquisition of F/M Investments, which manages over $10 billion in ETF assets.

21 ago 2026, 20:06 UTC

News

Salesforce Inc is higher as investor interest grows ahead of its August 26 earnings report, with a revenue target of $11.3 billion for Q2.

21 ago 2026, 20:06 UTC

News
Correlated Moves

EUR/SGD is trading lower despite a positive HCOB Eurozone Manufacturing PMI of 52.8, which exceeded forecasts and previous figures.

21 ago 2026, 20:06 UTC

News
Correlated Moves

Texas Instruments shares reached a 16-week low at $264.73, continuing a decline despite a year-over-year increase. Broader semiconductor sector weakness may be influencing sentiment.

21 ago 2026, 20:06 UTC

News
Correlated Moves

AXIS Capital Holdings shares are lower today, reflecting broader market trends and a decline in Hartford Financial Services Group. The overall market remains flat since Thursday.

21 ago 2026, 20:06 UTC

News

Clean Harbors sees earnings estimates raised to $3.14 per share, but shares are trading lower amid a broader market decline.

21 ago 2026, 20:06 UTC

News
Event
Correlated Moves

Elastic NV trades roughly flat since Thursday's close.

21 ago 2026, 20:06 UTC

Correlated Moves
News

SmartFinancial Inc shares trade near unchanged as the Russell 2000 Index rises. Analyst ratings show a consensus score of 2.57, reflecting stable sentiment.

21 ago 2026, 20:06 UTC

News

Church & Dwight is higher today, driven by gains in the Household Products sector. The company announced its participation in the Barclays Global Consumer Staples Conference.

21 ago 2026, 20:06 UTC

News

OPKO Health shares rise as Zacks improves Q3 2026 loss estimate to $0.06, despite Barrington's downgrade and mixed analyst ratings.

21 ago 2026, 20:06 UTC

News

A U.S. appeals court ruling allows Delta Air Lines' joint venture with Aeromexico to continue, boosting investor sentiment and driving shares higher.

21 ago 2026, 20:06 UTC

News
Correlated Moves

Olin Corp's shares are declining today amid broader market trends. Analyst sentiment remains cautious, with a consensus recommendation of "Reduce" from sixteen firms.

21 ago 2026, 20:06 UTC

News

Warner Music Group reports 11.3% streaming growth in Q2 2026, narrowing the gap with Spotify. Shares are advancing amid positive market sentiment.

21 ago 2026, 20:06 UTC

News
Correlated Moves

Gold prices are advancing, reaching a near three-month high, driven by U.S. Treasury bond buybacks and reduced Middle East conflict concerns.

21 ago 2026, 20:06 UTC

News
Social Media

Semtech shares are declining despite BMO Capital's Outperform rating and $155 price target. Earlier, the stock peaked before reversing direction.

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

-6.15% descenso

Estimación a 12 Meses

Media 17.25 USD  -6.15%

Máximo 18.5 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

0

Comprar

4

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat